|
Volumn 46, Issue 2, 2004, Pages 619-730
|
Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
BOARD OF TRUSTEES;
CONFLICT OF INTEREST;
ECONOMICS;
ETHICS;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
GOVERNMENT REGULATION;
GROUP PROCESS;
HUMAN;
HUMAN EXPERIMENT;
INTERPERSONAL COMMUNICATION;
LEGAL APPROACH;
LEGAL ASPECT;
LEGAL LIABILITY;
NATIONAL RESEARCH ACT;
ORGANIZATION;
ORGANIZATION AND MANAGEMENT;
PEER REVIEW;
PROFESSIONAL PRACTICE;
PROFESSIONAL STANDARD;
ROLE PLAYING;
SALARY AND FRINGE BENEFIT;
UNITED STATES;
WORKLOAD;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
LEGAL APPROACH;
NATIONAL RESEARCH ACT;
COMMITTEE MEMBERSHIP;
CONFLICT OF INTEREST;
DISCLOSURE;
ETHICAL REVIEW;
ETHICS COMMITTEES, RESEARCH;
GOVERNING BOARD;
GOVERNMENT REGULATION;
GROUP PROCESSES;
HUMAN EXPERIMENTATION;
HUMANS;
LIABILITY, LEGAL;
NEGOTIATING;
ORGANIZATIONAL CULTURE;
PEER REVIEW, RESEARCH;
PROFESSIONAL CORPORATIONS;
ROLE;
SALARIES AND FRINGE BENEFITS;
UNITED STATES;
UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
WORKLOAD;
|
EID: 27944447082
PISSN: 00435589
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (0)
|